|Astomax Fund Management||Japan, Tokyo|
|Changan Automobile||China, Chongqing, Jiangbei|
|Chengdu Hi-tech Investment Group||-|
|DraftKings||Boston, Massachusetts, United States|
|Emagen Investment Group, Inc.||California, Redondo Beach, United States|
|Garnett & Helfrich Capital||California, San Mateo, United States|
|Health Innovations||Netherlands, Utrecht, Utrecht|
|MedTech Actuator||Australia, Melbourne, Victoria|
|OMERS Private Equity||Canada, Ontario, Toronto|
|Ouest Angels Capital||France, Nantes, Pays de la Loire|
|RSS Investors Fund||-|
|RWE||Essen, Germany, Nordrhein-Westfalen|
|Somerset Capital||Colorado, Denver, United States|
|STS Ventures||Cologne, Germany, Nordrhein-Westfalen|
|The Angel Roundtable||Johnson City, Tennessee, United States|
|XYMAX ALPHA||Japan, Tokyo|
|$900K||17 Jan 2023||Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates|
|$6M||02 Dec 2014||London, England, United Kingdom|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.